They failed to find significant effect when looking at their primary endpoints in adults. They had to do more sub group trawling to find significance.
I think it's safe to say that's a fact. It's not a fact to say there's no significant effect, but it's a fact they failed to find one in their trial.
2023 Next Steps, page-117
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
0.015(1.53%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $3.237M | 3.189M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 89075 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 92439 | 39 |
View Market Depth
| Last trade - 13.47pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |